Preparation for the prevention and/or treatment of vascular disorders
AssigneeN. V. Nutricia
InventorsAmanda Johanne Kiliaan, Robert Johan Joseph Hageman
Life of this patent
Estimating the term…
Abstract
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
Claims27
A method for prevention and/or treatment of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes, comprising administering to a person in need thereof a preparation, comprising:
- a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA);
- b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine;
- and
- c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.
A method for prevention and/or treatment of vascular disorders or disorders associated therewith, comprising administering to a person in need thereof a preparation, comprising:
- a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA);
- b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine;
- and
- c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.
Dependencies are inferred from the claim text.